Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
Ciardiello D, Famiglietti V, Napolitano S, Esposito L, Normanno N, Avallone A, Latiano T, Maiello E, Pietrantonio F, Cremolini C, Santabarbara G, Pinto C, Troiani T, Martinelli E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: maiello e. Cancers (Basel). 2021 Nov 15;13(22):5715. doi: 10.3390/cancers13225715. Cancers (Basel). 2021. PMID: 34830870 Free PMC article.
Cetuximab: clinical results in colorectal cancer.
Maiello E, Giuliani F, Gebbia V, Piano A, Agueli R, Colucci G. Maiello E, et al. Ann Oncol. 2007 Jun;18 Suppl 6:vi8-10. doi: 10.1093/annonc/mdm216. Ann Oncol. 2007. PMID: 17591840 Free article. Review.
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.
Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P. Barbano R, et al. Among authors: maiello e. Int J Cancer. 2011 Aug 1;129(3):536-45. doi: 10.1002/ijc.25736. Epub 2010 Dec 9. Int J Cancer. 2011. PMID: 21064098
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).
Pinto C, Di Fabio F, Maiello E, Pini S, Latiano T, Aschele C, Garufi C, Bochicchio A, Rosati G, Aprile G, Giaquinta S, Torri V, Bardelli A, Gion M, Martoni A. Pinto C, et al. Among authors: maiello e. Ann Oncol. 2011 Nov;22(11):2424-2430. doi: 10.1093/annonc/mdq782. Epub 2011 Mar 8. Ann Oncol. 2011. PMID: 21385884 Free article. Clinical Trial.
Combined modality treatments in pancreatic cancer.
Lombardi L, Troiano M, Silvestris N, Nanni L, Latiano TP, Di Maggio G, Cinieri S, Di Sebastiano P, Colucci G, Maiello E. Lombardi L, et al. Among authors: maiello e. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S71-81. doi: 10.1517/14728222.2012.662959. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443336 Review.
Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E. Lombardi L, et al. Among authors: maiello e. Crit Rev Oncol Hematol. 2013 Dec;88(3):696-705. doi: 10.1016/j.critrevonc.2013.08.005. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2013. PMID: 24120239 Review.
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.
Ciardiello F, Normanno N, Maiello E, Martinelli E, Troiani T, Pisconti S, Giuliani F, Barone C, Cartenì G, Rachiglio AM, Montesarchio V, Tonini G, Rizzi D, Cinieri S, Bordonaro R, Febbraro A, De Vita F, Orditura M, Fenizia F, Lambiase M, Rinaldi A, Tatangelo F, Botti G, Colucci G. Ciardiello F, et al. Among authors: maiello e. Ann Oncol. 2014 Sep;25(9):1756-1761. doi: 10.1093/annonc/mdu230. Epub 2014 Jun 18. Ann Oncol. 2014. PMID: 24942275 Free article.
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.
Silvestris N, Scartozzi M, Graziano G, Santini D, Lorusso V, Maiello E, Barni S, Cinieri S, Loupakis F, Pisconti S, Brunetti AE, Palasciano G, Palmieri VO, Del Prete M, Dell'Aquila E, Latiano TP, Petrelli F, Lutrino S, Rossini D, Giampieri R, Lotesoriere C, Cascinu S. Silvestris N, et al. Among authors: maiello e. Expert Opin Biol Ther. 2015 Feb;15(2):155-62. doi: 10.1517/14712598.2015.986452. Epub 2014 Nov 19. Expert Opin Biol Ther. 2015. PMID: 25411089
278 results